The value of genetic and pharmacological approaches to understanding the complexities of GABAA receptor subtype functions: The anxiolytic effects of benzodiazepines

Pharmacology Biochemistry and Behavior

Volumn 90, Issue 1, 2008, Pages 37-42

  Reynolds, David S ^a  

^a PFIZER GLOBAL RESEARCH AND DEVELOPMENT   (United Kingdom)

Author keywords

Anxiety; Benzodiazepine; GABA; Knock in; Transgenic

Indexed keywords

4 AMINOBUTYRIC ACID A RECEPTOR; 6 FLUORO 2,9 DIHYDRO 9 METHYL 2 PHENYL 4 (1 PYRROLIDINYLCARBONYL) 1H PYRIDO[3,4 B]INDOL 1 ONE; 7 TERT BUTYL 3 (2,5 DIFLUOROPHENYL) 6 (2 METHYL 2H 1,2,4 TRIAZOL 3 YLMETHOXY) 1,2,4 TRIAZOLO[4,3 B]PYRIDAZINE; ARGININE; BENZODIAZEPINE; BRETAZENIL; CHLORDIAZEPOXIDE; DIAZEPAM; ETOMIDATE; HISTIDINE; PAGOCLONE; PROPOFOL; RECEPTOR SUBUNIT; ZOLPIDEM;

DRUG ACTIVITY; DRUG BINDING SITE; DRUG EFFECT; DRUG EFFICACY; DRUG MECHANISM; DRUG SENSITIVITY; GENE SEQUENCE; GENETIC MANIPULATION; NONHUMAN; PRIORITY JOURNAL; REVIEW; SEDATION; TRANQUILIZING ACTIVITY;

ANIMALS; ANTI-ANXIETY AGENTS; BENZODIAZEPINES; GABA MODULATORS; MICE; MICE, KNOCKOUT; RECEPTORS, GABA-A;

EID: 44649106341     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pbb.2008.03.015     Document Type: Review

References (77)

1. Amin J., Brooks-Kayal A., and Weiss D.S. Two tyrosine residues on the alpha subunit are crucial for benzodiazepine binding and allosteric modulation of gamma-aminobutyric acidA receptors. Mol Pharmacol 51 (1997) 833-841
2. Atack J.R. The benzodiazepine binding site of GABA(A) receptors as a target for the development of novel anxiolytics. Expert Opin Investig Drugs 14 (2005) 601-618
3. Atack J.R., Hutson P.H., Collinson N., Marshall G., Bentley G., Moyes C., et al. Anxiogenic properties of an inverse agonist selective for alpha3 subunit-containing GABA A receptors. Br J Pharmacol 144 (2005) 357-366
4. Atack J.R., Pike A., Marshall G., Stanley J., Lincoln R., Cook S.M., et al. The in vivo properties of pagoclone in rat are most likely mediated by 5′-hydroxy pagoclone. Neuropharmacology 50 (2006) 677-689
5. Atack J.R., Wafford K.A., Tye S.J., Cook S.M., Sohal B., Pike A., et al. TPA023 [7-(1,1-dimethylethyl)-6-(2-ethyl-2H-1,2,4-triazol-3-ylmethoxy)-3-(2-fluor ophenyl)-1,2,4-triazolo[4,3-b]pyridazine], an agonist selective for alpha2-and alpha3-containing GABAA receptors, is a nonsedating anxiolytic in rodents and primates. J Pharmacol Exp Ther 316 (2006) 410-422
6. Barnard E.A., Skolnick P., Olsen R.W., Mohler H., Sieghart W., Biggio G., et al. International Union of Pharmacology. XV. Subtypes of gamma-aminobutyric acidA receptors: classification on the basis of subunit structure and receptor function. Pharmacol Rev 50 (1998) 291-313
7. Bowery N.G. Allosteric receptor modulation in drug targeting (2006), Taylor and Francis, New York
8. Brickley S.G., Revilla V., Cull-Candy S.G., Wisden W., and Farrant M. Adaptive regulation of neuronal excitability by a voltage-independent potassium conductance. Nature 409 (2001) 88-92
9. Buhr A., Schaerer M.T., Baur R., and Sigel E. Residues at positions 206 and 209 of the alpha1 subunit of gamma-aminobutyric AcidA receptors influence affinities for benzodiazepine binding site ligands. Mol Pharmacol 52 (1997) 676-682
10. Collinson N., Kuenzi F.M., Jarolimek W., Maubach K.A., Cothliff R., Sur C., et al. Enhanced learning and memory and altered GABAergic synaptic transmission in mice lacking the alpha 5 subunit of the GABAA receptor. J Neurosci 22 (2002) 5572-5580
11. Crestani F., Keist R., Fritschy J.M., Benke D., Vogt K., Prut L., et al. Trace fear conditioning involves hippocampal alpha5 GABA(A) receptors. Proc Natl Acad Sci U S A 99 (2002) 8980-8985
12. Crestani F., Lorez M., Baer K., Essrich C., Benke D., Laurent J.P., et al. Decreased GABAA-receptor clustering results in enhanced anxiety and a bias for threat cues. Nat Neurosci 2 (1999) 833-839
13. Crestani F., Mohler H., and Rudolph U. Anxiolytic-like action of diazepam: mediated by GABAA receptors containing the α2-subunit. Response from Crestani et al. Trends Pharmacol Sci 22 (2001) 403
14. Culiat C.T., Stubbs L.J., Woychik R.P., Russell L.B., Johnson D.K., and Rinchik E.M. Deficiency of the beta 3 subunit of the type A gamma-aminobutyric acid receptor causes cleft palate in mice. Nat Genet 11 (1995) 344-346
15. Dawson G.R., Crawford S.P., Stanhope K.J., Iversen S.D., and Tricklebank M.D. One-trial tolerance to the effects of chlordiazepoxide on the elevated plus maze may be due to locomotor habituation, not repeated drug exposure. Psychopharmacology (Berl) 113 (1994) 570-572
16. Depoortere H., Zivkovic B., Lloyd K.G., Sanger D.J., Perrault G., Langer S.Z., et al. a novel nonbenzodiazepine hypnotic. I. Neuropharmacological and behavioral effects. J Pharmacol Exp Ther 237 (1986) 649-658
17. Dias R., Sheppard W.F., Fradley R.L., Garrett E.M., Stanley J.L., Tye S.J., et al. Evidence for a significant role of alpha 3-containing GABAA receptors in mediating the anxiolytic effects of benzodiazepines. J Neurosci 25 (2005) 10682-10688
18. File S.E. One-trial tolerance to the anxiolytic effects of chlordiazepoxide in the plus-maze. Psychopharmacology (Berl) 100 (1990) 281-282
19. Florey E. GABA: history and perspectives. Can J Physiol Pharmacol 69 (1991) 1049-1056
20. Fradley R.L., Guscott M.R., Bull S., Hallett D.J., Goodacre S.C., Wafford K.A., et al. Differential contribution of GABA(A) receptor subtypes to the anticonvulsant efficacy of benzodiazepine site ligands. J Psychopharmacol 21 (2007) 384-391
21. Franks N.P., and Lieb W.R. Molecular and cellular mechanisms of general anaesthesia. Nature 367 (1994) 607-614
22. Griebel G., Perrault G., Simiand J., Cohen C., Granger P., Decobert M., et al. SL651498: an anxioselective compound with functional selectivity for alpha2-and alpha3-containing gamma-aminobutyric acid(A) (GABA(A)) receptors. J Pharmacol Exp Ther 298 (2001) 753-768
23. Gunther U., Benson J., Benke D., Fritschy J.M., Reyes G., Knoflach F., et al. Benzodiazepine-insensitive mice generated by targeted disruption of the gamma 2 subunit gene of gamma-aminobutyric acid type A receptors. Proc Natl Acad Sci U S A 92 (1995) 7749-7753
24. Haefely W., Martin J.R., and Schoch P. Novel anxiolytics that act as partial agonists at benzodiazepine receptors. Trends Pharmacol Sci 11 (1990) 452-456
25. Homanics G.E., DeLorey T.M., Firestone L.L., Quinlan J.J., Handforth A., Harrison N.L., et al. Mice devoid of gamma-aminobutyrate type A receptor beta3 subunit have epilepsy, cleft palate, and hypersensitive behavior. Proc Natl Acad Sci U S A 94 (1997) 4143-4148
26. Jackson M.B., Lecar H., Mathers D.A., and Barker J.L. Single channel currents activated by gamma-aminobutyric acid, muscimol, and (-)-pentobarbital in cultured mouse spinal neurons. J Neurosci 2 (1982) 889-894
27. Jones A., Korpi E.R., McKernan R.M., Pelz R., Nusser Z., Makela R., et al. Ligand-gated ion channel subunit partnerships: GABAA receptor alpha6 subunit gene inactivation inhibits delta subunit expression. J Neurosci 17 (1997) 1350-1362
28. Jurd R., Arras M., Lambert S., Drexler B., Siegwart R., Crestani F., et al. General anesthetic actions in vivo strongly attenuated by a point mutation in the GABA(A) receptor beta3 subunit. Faseb J 17 (2003) 250-252
29. Korpi E.R., Mihalek R.M., Sinkkonen S.T., Hauer B., Hevers W., Homanics G.E., et al. Altered receptor subtypes in the forebrain of GABA(A) receptor delta subunit-deficient mice: recruitment of gamma 2 subunits. Neuroscience 109 (2002) 733-743
30. Kralic J.E., Korpi E.R., O'Buckley T.K., Homanics G.E., and Morrow A.L. Molecular and pharmacological characterization of GABA(A) receptor alpha1 subunit knockout mice. J Pharmacol Exp Ther 302 (2002) 1037-1045
31. Kralic J.E., O'Buckley T.K., Khisti R.T., Hodge C.W., Homanics G.E., and Morrow A.L. GABA(A) receptor alpha-1 subunit deletion alters receptor subtype assembly, pharmacological and behavioral responses to benzodiazepines and zolpidem. Neuropharmacology 43 (2002) 685-694
32. Krnjevic K. How does a little acronym become a big transmitter?. Biochem Pharmacol 68 (2004) 1549-1555
33. Langen B., Egerland U., Bernoster K., Dost R., Unverferth K., and Rundfeldt C. Characterization in rats of the anxiolytic potential of ELB139 [1-(4-chlorophenyl)-4-piperidin-1-yl-1,5-dihydro-imidazol-2-on], a new agonist at the benzodiazepine binding site of the GABAA receptor. J Pharmacol Exp Ther 314 (2005) 717-724
34. Laurie D.J., Seeburg P.H., and Wisden W. The distribution of 13 GABAA receptor subunit mRNAs in the rat brain. II. Olfactory bulb and cerebellum. J Neurosci 12 (1992) 1063-1076
35. LeDoux J.E. Emotion circuits in the brain. Annu Rev Neurosci 23 (2000) 155-184
36. Levitan E.S., Schofield P.R., Burt D.R., Rhee L.M., Wisden W., Kohler M., et al. Structural and functional basis for GABAA receptor heterogeneity. Nature 335 (1988) 76-79
37. Liu R., Hu R.J., Zhang P., Skolnick P., and Cook J.M. Synthesis and pharmacological properties of novel 8-substituted imidazobenzodiazepines: high-affinity, selective probes for alpha 5-containing GABAA receptors. J Med Chem 39 (1996) 1928-1934
38. Low K., Crestani F., Keist R., Benke D., Brunig I., Benson J.A., et al. Molecular and neuronal substrate for the selective attenuation of anxiety. Science 290 (2000) 131-134
39. Mathiasen L., and Mirza N.R. A comparison of chlordiazepoxide, bretazenil, L838,417 and zolpidem in a validated mouse Vogel conflict test. Psychopharmacology (Berl) 182 (2005) 475-484
40. Mathiasen L.S., Rodgers R.J., and Mirza N.R. Comparative effects of nonselective and subtype-selective gamma-aminobutyric acidA receptor positive modulators in the rat-conditioned emotional response test. Behav Pharmacol 18 (2007) 191-203
41. McCabe C., Shaw D., Atack J.R., Street L.J., Wafford K.A., Dawson G.R., et al. Subtype-selective GABAergic drugs facilitate extinction of mouse operant behaviour. Neuropharmacology 46 (2004) 171-178
42. McKernan R.M., Rosahl T.W., Reynolds D.S., Sur C., Wafford K.A., Atack J.R., et al. Sedative but not anxiolytic properties of benzodiazepines are mediated by the GABA(A) receptor alpha1 subtype. Nat Neurosci 3 (2000) 587-592
43. McKernan R.M., and Whiting P.J. Which GABAA-receptor subtypes really occur in the brain?. Trends Neurosci 19 (1996) 139-143
44. Mohler H., Fritschy J.M., and Rudolph U. A new benzodiazepine pharmacology. J Pharmacol Exp Ther 300 (2002) 2-8
45. Morris H.V., Dawson G.R., Reynolds D.S., Atack J.R., and Stephens D.N. Both alpha2 and alpha3 GABAA receptor subtypes mediate the anxiolytic properties of benzodiazepine site ligands in the conditioned emotional response paradigm. Eur J Neurosci 23 (2006) 2495-2504
46. Nemeroff C.B. Anxiolytics: past, present, and future agents. J Clin Psychiatry 64 Suppl 3 (2003) 3-6
47. Ortells M.O., and Lunt G.G. Evolutionary history of the ligand-gated ion-channel superfamily of receptors. Trends Neurosci 18 (1995) 121-127
48. Peng Z., Hauer B., Mihalek R.M., Homanics G.E., Sieghart W., Olsen R.W., et al. GABA(A) receptor changes in delta subunit-deficient mice: altered expression of alpha4 and gamma2 subunits in the forebrain. J Comp Neurol 446 (2002) 179-197
49. Persohn E., Malherbe P., and Richards J.G. Comparative molecular neuroanatomy of cloned GABAA receptor subunits in the rat CNS. J Comp Neurol 326 (1992) 193-216
50. Pirker S., Schwarzer C., Wieselthaler A., Sieghart W., and Sperk G. GABA(A) receptors: immunocytochemical distribution of 13 subunits in the adult rat brain. Neuroscience 101 (2000) 815-850
51. Prenosil G.A., Schneider Gasser E.M., Rudolph U., Keist R., Fritschy J.M., and Vogt K.E. Specific subtypes of GABAA receptors mediate phasic and tonic forms of inhibition in hippocampal pyramidal neurons. J Neurophysiol 96 (2006) 846-857
52. Quirk K., Blurton P., Fletcher S., Leeson P., Tang F., Mellilo D., et al. [3H]L-655,708, a novel ligand selective for the benzodiazepine site of GABAA receptors which contain the alpha 5 subunit. Neuropharmacology 35 (1996) 1331-1335
53. Rabe H., Kronbach C., Rundfeldt C., and Luddens H. The novel anxiolytic ELB139 displays selectivity to recombinant GABA(A) receptors different from diazepam. Neuropharmacology 52 (2007) 796-801
54. Reynolds D.S., McKernan R.M., and Dawson G.R. Anxiolytic-like action of diazepam: which GABA(A) receptor subtype is involved?. Trends Pharmacol Sci 22 (2001) 402-403
55. Reynolds D.S., O'Meara G.F., Newman R.J., Bromidge F.A., Atack J.R., Whiting P.J., et al. GABA(A) alpha 1 subunit knock-out mice do not show a hyperlocomotor response following amphetamine or cocaine treatment. Neuropharmacology 44 (2003) 190-198
56. Reynolds D.S., Rosahl T.W., Cirone J., O'Meara G.F., Haythornthwaite A., Newman R.J., et al. Sedation and anesthesia mediated by distinct GABA(A) receptor isoforms. J Neurosci 23 (2003) 8608-8617
57. Rowlett J.K., Platt D.M., Lelas S., Atack J.R., and Dawson G.R. Different GABAA receptor subtypes mediate the anxiolytic, abuse-related, and motor effects of benzodiazepine-like drugs in primates. Proc Natl Acad Sci U S A 102 (2005) 915-920
58. Rudolph U., Crestani F., Benke D., Brunig I., Benson J.A., Fritschy J.M., et al. Benzodiazepine actions mediated by specific gamma-aminobutyric acid(A) receptor subtypes. Nature 401 (1999) 796-800
59. Sanger D.J. The pharmacology and mechanisms of action of new generation, non-benzodiazepine hypnotic agents. CNS Drugs 18 Suppl 1 (2004) 9-15 discussion 41, 43-15
60. Schofield P.R., Darlison M.G., Fujita N., Burt D.R., Stephenson F.A., Rodriguez H., et al. Sequence and functional expression of the GABA A receptor shows a ligand-gated receptor super-family. Nature 328 (1987) 221-227
61. Schwarzer C., Berresheim U., Pirker S., Wieselthaler A., Fuchs K., Sieghart W., et al. Distribution of the major gamma-aminobutyric acid(A) receptor subunits in the basal ganglia and associated limbic brain areas of the adult rat. J Comp Neurol 433 (2001) 526-549
62. Selleri S., Bruni F., Costagli C., Costanzo A., Guerrini G., Ciciani G., et al. A novel selective GABA(A) alpha1 receptor agonist displaying sedative and anxiolytic-like properties in rodents. J Med Chem 48 (2005) 6756-6760
63. Sigel E. Mapping of the benzodiazepine recognition site on GABA(A) receptors. Curr Top Med Chem 2 (2002) 833-839
64. Skolnick P., Hu R.J., Cook C.M., Hurt S.D., Trometer J.D., Liu R., et al. [3H]RY 80: A high-affinity, selective ligand for gamma-aminobutyric acidA receptors containing alpha-5 subunits. J Pharmacol Exp Ther 283 (1997) 488-493
65. Smith A.J., Alder L., Silk J., Adkins C., Fletcher A.E., Scales T., et al. Effect of alpha subunit on allosteric modulation of ion channel function in stably expressed human recombinant gamma-aminobutyric acid(A) receptors determined using (36)Cl ion flux. Mol Pharmacol 59 (2001) 1108-1118
66. Sprengel R., and Hasan M.T. Tetracycline-controlled genetic switches. Handb Exp Pharmacol (2007) 49-72
67. Stjarne L. Catecholaminergic neurotransmission: flagship of all neurobiology. Acta Physiol Scand 166 (1999) 251-259
68. Sur C., Wafford K.A., Reynolds D.S., Hadingham K.L., Bromidge F., Macaulay A., et al. Loss of the major GABA(A) receptor subtype in the brain is not lethal in mice. J Neurosci 21 (2001) 3409-3418
69. Toufexis D. Region- and sex-specific modulation of anxiety behaviours in the rat. J Neuroendocrinol 19 (2007) 461-473
70. Uusi-Oukari M., Heikkila J., Sinkkonen S.T., Makela R., Hauer B., Homanics G.E., et al. Long-range interactions in neuronal gene expression: evidence from gene targeting in the GABA(A) receptor beta2-alpha6-alpha1-gamma2 subunit gene cluster. Mol Cell Neurosci 16 (2000) 34-41
71. van Steveninck A.L., Gieschke R., Schoemaker R.C., Roncari G., Tuk B., Pieters M.S., et al. Pharmacokinetic and pharmacodynamic interactions of bretazenil and diazepam with alcohol. Br J Clin Pharmacol 41 (1996) 565-573
72. Wafford K.A., Macaulay A.J., Fradley R., O'Meara G.F., Reynolds D.S., and Rosahl T.W. Differentiating the role of gamma-aminobutyric acid type A (GABAA) receptor subtypes. Biochem Soc Trans 32 (2004) 553-556
73. Walker D.L., Toufexis D.J., and Davis M. Role of the bed nucleus of the stria terminalis versus the amygdala in fear, stress, and anxiety. Eur J Pharmacol 463 (2003) 199-216
74. Whiting P.J., McKernan R.M., and Wafford K.A. Structure and pharmacology of vertebrate GABAA receptor subtypes. Int Rev Neurobiol 38 (1995) 95-138
75. Wieland H.A., Luddens H., and Seeburg P.H. A single histidine in GABAA receptors is essential for benzodiazepine agonist binding. J Biol Chem 267 (1992) 1426-1429
76. Wingrove P.B., Safo P., Wheat L., Thompson S.A., Wafford K.A., and Whiting P.J. Mechanism of alpha-subunit selectivity of benzodiazepine pharmacology at gamma-aminobutyric acid type A receptors. Eur J Pharmacol 437 (2002) 31-39
77. Wisden W., Laurie D.J., Monyer H., and Seeburg P.H. The distribution of 13 GABAA receptor subunit mRNAs in the rat brain. I. Telencephalon, diencephalon, mesencephalon. J Neurosci 12 (1992) 1040-1062